BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9273073)

  • 1. [Volume and spatial representation of tumors in the core of the prostate gland].
    Salomon L; Colombel M; Patard JJ; Bellot J; Vogt B; Lefrère-Belda MA; Chopin D; Abbou CC
    Prog Urol; 1997 Jun; 7(3):442-8. PubMed ID: 9273073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.
    van Oort IM; Witjes JA; Kok DE; Kiemeney LA; Hulsbergen-Van De Kaa CA
    BJU Int; 2008 Aug; 102(4):438-41. PubMed ID: 18336608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of biopsies in staging of prostatic cancer before radical prostatectomy].
    Salomon L; Hoznek A; Lefrere-Belda MA; Bellot J; Chopin D; Abbou CC
    Prog Urol; 1998 Dec; 8(6):969-76. PubMed ID: 9894255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
    BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systematic morphometry of radical prostatectomy samples. A guideline for general practice].
    Schmid HP; McNeal JE; Redwine EA; Freiha FS; Stamey TA
    Helv Chir Acta; 1992 Oct; 59(3):471-6. PubMed ID: 1464544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical staging error in prostate cancer: localization and relevance of undetected tumour areas.
    Bolenz C; Gierth M; Grobholz R; Köpke T; Semjonow A; Weiss C; Alken P; Michel MS; Trojan L
    BJU Int; 2009 May; 103(9):1184-9. PubMed ID: 19154463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting tumor volume in radical prostatectomy specimens from patients with prostate cancer.
    Eichelberger LE; Koch MO; Daggy JK; Ulbright TM; Eble JN; Cheng L
    Am J Clin Pathol; 2003 Sep; 120(3):386-91. PubMed ID: 14502802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.
    Poulos CK; Daggy JK; Cheng L
    Cancer; 2004 Aug; 101(3):527-32. PubMed ID: 15274065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.
    Steuber T; Erbersdobler A; Graefen M; Haese A; Huland H; Karakiewicz PI
    Cancer; 2006 Feb; 106(4):775-82. PubMed ID: 16400637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2005 Mar; 12(3):270-4. PubMed ID: 15828954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy.
    Ward JF; Nakanishi H; Pisters L; Babaian RJ; Troncoso P
    BJU Int; 2009 Aug; 104(4):490-7. PubMed ID: 19220260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The independent impact of extended pattern biopsy on prostate cancer stage migration.
    Master VA; Chi T; Simko JP; Weinberg V; Carroll PR
    J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of touch preparation cytological evaluation and prostatic capsule involvement in prediction of prostate cancer recurrence.
    Brannigan RE; Shin E; Rademaker A; Oyasu R; Huang CF; Pearle MS; McVary KT
    J Urol; 1998 Nov; 160(5):1741-7. PubMed ID: 9783944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
    Eskicorapci SY; Guliyev F; Akdogan B; Dogan HS; Ergen A; Ozen H
    J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a relationship between prostate volume and Gleason score?
    Mir MC; Planas J; Raventos CX; de Torres IM; Trilla E; Cecchini L; Orsola A; Morote J
    BJU Int; 2008 Aug; 102(5):563-5. PubMed ID: 18476971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One core positive prostate biopsy is a poor predictor of cancer volume in the radical prostatectomy specimen.
    Wang X; Brannigan RE; Rademaker AW; McVary KT; Oyasu R
    J Urol; 1997 Oct; 158(4):1431-5. PubMed ID: 9302137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostate carcinoma (PC)--an organ-related specific pathological neoplasm].
    Massmann J; Funk A; Altwein J; Praetorius M
    Radiologe; 2003 Jun; 43(6):423-31. PubMed ID: 12827256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.